Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mediastinal epithelial neoplasms with recurrent molecular alterations.

Mediastinum (Hong Kong, China)·2026
Same author

Histiocyte-Rich Renal Epithelial Neoplasm: A Morphology Associated With Folliculin Mutations and Birt-Hogg-Dubé Syndrome.

The American journal of surgical pathology·2026
Same author

Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites.

Archives of pathology & laboratory medicine·2026
Same author

NF2/Merlin Immunohistochemistry Helps Distinguish Collecting Duct Carcinoma From Upper Tract Urothelial Carcinoma.

The American journal of surgical pathology·2026
Same author

Immunohistochemical characterization of somatically derived "yolk sac tumors": analysis of a multi-institutional case series.

Virchows Archiv : an international journal of pathology·2026
Same author

MDM2 gene amplification in surgical pathology: biology, diagnostic utility, and clinical relevance in the modern era.

Seminars in diagnostic pathology·2026

Related Experiment Video

Updated: Aug 22, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

738

Prostate Cancer: Update on Grading and Reporting.

Ezra Baraban1, Jonathan Epstein2

  • 1Department of Pathology, Johns Hopkins Medical Institutions, 401 North Broadway, Weinberg Building, Room 2242, Baltimore, MD 21287, USA.

Surgical Pathology Clinics
|November 7, 2022
PubMed
Summary
This summary is machine-generated.

Accurate prostate cancer grading is vital for surgical pathologists. Recognizing Gleason Pattern 4 is crucial, but certain conditions like therapy effects or specific differentiations can mimic aggressive features, leading to potential overgrading.

Keywords:
Gleason scoringGrade groupsIntraductal carcinomaProstate cancerProstatic adenocarcinoma with Paneth cell–like differentiationProstatic adenocarcinoma with aberrant P63 expression

More Related Videos

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

149
Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:30

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

180

Related Experiment Videos

Last Updated: Aug 22, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

738
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

149
Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:30

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

180

Area of Science:

  • Uropathology
  • Surgical Pathology
  • Oncology

Background:

  • Accurate grading of prostate cancer is essential for patient management and treatment decisions.
  • The Gleason scoring system and Grade Group systems are standard tools for prostate cancer grading.
  • Gleason Pattern 4 is a key indicator of potentially more aggressive disease compared to Gleason Pattern 3.

Purpose of the Study:

  • To highlight critical aspects of prostate cancer grading for surgical pathologists.
  • To identify specific entities that can be mistaken for aggressive prostate cancer.
  • To emphasize the importance of avoiding overgrading in challenging cases.

Main Methods:

  • Review of histopathological features in prostate adenocarcinoma.
  • Analysis of specific architectural patterns and cellular morphologies.
  • Correlation of morphological findings with clinical behavior and treatment effects.

Main Results:

  • Gleason Pattern 4 is a significant predictor of aggressive prostate cancer.
  • Prostatic adenocarcinoma with therapy effects (radiation/androgen), aberrant P63 expression, or Paneth cell-like differentiation can mimic aggressive patterns.
  • These specific conditions do not reflect true aggressive biologic potential despite architectural similarities to Gleason Pattern 4.

Conclusions:

  • Surgical pathologists must be aware of pitfalls in prostate cancer grading.
  • Misinterpretation of specific features can lead to significant overstatement of tumor biologic potential.
  • Accurate differentiation is crucial to avoid overtreatment and ensure appropriate patient management.